Shukra Pharmaceuticals Ltd — Updates, 27-06-2025: Company Update

Shukra Pharmaceuticals Limited has announced a board meeting on which it received a Letter of Acceptance from Rajasthan Medical Services Corporation Limited for a Rate Contract cum Supply Agreement valued at ₹11.59 Cr. The contract involves supplying essential pharmaceutical formulations to government health institutions across Rajasthan, with deliveries scheduled through December 2026. This win strengthens Shukra’s position in the public healthcare sector, enhances its institutional sales visibility, and supports its strategic goal to expand government procurement partnerships, potentially boosting revenues in coming quarters.